COVID-19 Impact

You may see some delays in posting new content due to COVID-19. If you have any questions, please submit a message to PSNet Support.

PSNet: Patient Safety Network
Web Resource
Government Resource

Differences in strength expression on product labels of compounders and conventional manufacturers may lead to dosing errors.

US Food and Drug Administration; FDA.

Confusing labeling can affect safe medication preparation and administration. This safety announcement reviews case reports associated with inconsistent drug strength information that contributed to dosing errors of compounded injectable products.